CSL Vifor is seeking a senior Clinical Development leader to provide strategic medical leadership for global clinical programs across the CVR therapeutic area. You will represent medical science on leadership teams, guide development strategies, and drive high-quality clinical content
Seit über 100 Jahren führend – AIG ist als weltweit agierendes Versicherungsunternehmen auf die Absicherung komplexer und ungewöhnlicher Risiken spezialisiert. Multinationale Konzerne, lokale Unternehmen und anspruchsvolle Privatkunden vertrauen auf unsere umfassende Expertise und maßgeschneiderten Lösungen. In
Main Responsibilities and Accountabilities: Providing s trategic and tactical M edical & Scientific leadership and guidance for clinical development activities for 5-8 Global Clinical Program Leaders (GCPL) Serving as the CD representatiin on the Therapeutic Area Leadership team
The Director Non-Clinical Due Diligence & External Evaluations providesscientific leadership for nonclinical due diligencesupporting CSL’s in-licensing, acquisitions, and strategic collaborations. The role ensuresintegrated, objective, and decision-relevant evaluationsof nonclinical pharmacology, PK/QSP, and toxicology data to identify development risks,
You will lead Climeworks’ global Health, Safety, Security and Environmental (HSSE) function, ensuring a consistent and high-performing safety culture across our production facilities, testing sites and corporate environments. At the same time, you will oversee corporate
The Director Non-Clinical Due Diligence & External Evaluations provides scientific leadership for nonclinical due diligence supporting CSL’s in‑licensing, acquisitions, and strategic collaborations. The role ensures integrated, objective, and decision‑relevant evaluations of nonclinical pharmacology, PK/QSP, and toxicology
Position Purpose: Ensure Corporate & External Affairs liaison with commercial and site leadership in Switzerland. Provide strategic guidance and direction to the affiliate and site leadership teams on government relations, policy, and advocacy, enable early identification